Inverse Biotech Suddenly Cool Kid at ETF Party
April 04, 2014 at 15:02 PM EDT
Biotechnology exchange traded funds are looking under the weather, with investors taking profits after an impressive bull run. Meanwhile, some aggressive traders are capitalizing on Biotech’s misery with the leveraged exchange traded fund. The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB)...